Expanded access programs are pathways for patients with serious or life-threatening diseases to access drugs in development outside of clinical trials when there are no other treatment options available. These programs are also known by other names, such as Compassionate Use, Early Access Programs, Managed Access Programs and Named Patient Programs. They are primarily driven by physicians on behalf of their patients.
myTomorrows Team
6 Mar 2025
11 mins read
myTomorrows Team
25 Feb 2025
10 mins read
myTomorrows Team
25 Feb 2025
5 mins read
myTomorrows Team
17 Feb 2025
5 mins read
myTomorrows Team
11 Feb 2025
11 mins read
Danny den Hamer
6 Feb 2025
6 mins read
Romina Dibra
14 Jan 2025
7 mins read
myTomorrows Team
17 Dec 2024
4 mins read
myTomorrows Team
12 Dec 2024
9 mins read
myTomorrows Team
22 Nov 2024
4 mins read